Titomic headed into this half year on the back of a share price that closed at A$0.17 on 28 August and a 3 month slide of about 31%. The market had already marked the stock down. The earnings release explains why. Revenue for H1 2026 came in at about A$4.9m, yet the company booked a net loss of roughly A$19.4m and basic earnings per share stayed firmly in the red.
This time the focus is not on revenue. It is on the scale of the ongoing loss and what that implies for Titomic’s already tight cash runway and rich P/S multiple.
Is Titomic’s rich 27.5x P/S multiple a warning sign, or does the reported gap between its A$0.17 share price and A$0.31 fair value hint at mispricing? See how the current assumptions stack up in our valuation analysis for Titomic
Prefer clean charts over another wall of numbers? View Titomic’s full financial picture with a clear presentation of its balance sheet strength in our company report for Titomic.
Titomic still offers a growth angle for investors who focus on exposure to advanced manufacturing in defense and aerospace. Revenue for H1 2026 is higher than the prior period, which supports the idea that the technology is finding paying customers. Longer term holders have also seen a modest positive 7 day return into the 28 August close. Together, those signals suggest there is still some market confidence that Titomic’s cold spray and coating offering can build commercial traction, even if the financial base is not yet profitable.
The bearish side of the Titomic story is firmly anchored in the widening losses. The net loss for H1 2026 is sharply larger than a year earlier and the trailing 12 month loss has also grown. Basic EPS has moved further into loss territory. Those trends keep questions about cash runway and funding firmly on the table. The 90 day share price decline of about 31% also shows investors have already responded to these pressures as of late August 2026.
With Titomic reported to have less than 1 year of cash runway and no current profitability forecast, you may want to review whether these headline figures mask deeper structural issues. Scan the independent risk analysis for Titomic which shows 2 important warning signs for a concise breakdown of potential hidden vulnerabilities and how they stack up in one place.
If Titomic’s widening losses and gap between share price and fair value have your attention, register for free with Simply Wall St and add it to a Watchlist to track price moves against valuation and monitor potential entry points that align with your plan. After you own any stock, use the Portfolio Command Center to cut through market noise and focus on the updates that relate most to your holdings. For a longer term view, tap into the Community to see how other investors are thinking about risks, catalysts, and possible turning points. This can help you notice important shifts early, manage risk with greater clarity, and stay a step ahead of the market.
Fresh ideas get crowded fast. Before the next breakout rushes higher and momentum names start flying, scan under the radar for now stocks while it matters and get in early.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com